论文已发表
注册即可获取德孚的最新动态
IF 收录期刊
广泛耐药结核性脑膜炎患者血浆和脑脊液中抗结核药物的药代动力学
Authors Liang Z , Liao W , Chen Q, Li H , Ye M, Zou J, Deng G , Zhang P
Received 13 December 2022
Accepted for publication 6 March 2023
Published 23 March 2023 Volume 2023:16 Pages 1669—1676
DOI https://doi.org/10.2147/IDR.S401281
Checked for plagiarism Yes
Review by Single anonymous peer review
Peer reviewer comments 2
Editor who approved publication: Professor Suresh Antony
Abstract: Drug-resistant tuberculous meningitis (TBM) is the most devastating and critical form of extrapulmonary tuberculosis. Here, we present a case of a 45-year-old male with pre-extensive drug-resistant tuberculosis meningitis (pre-XDR-TBM). He underwent emergency surgery for the long-tunneled external ventricular drainage (LTEVD). Molecular test and phenotypic drug sensitivity test (DST) of Mycobacterium tuberculosis in cerebrospinal fluid (CSF) showed that the isolate was resistant to both rifampin and fluoroquinolones. An anti-tuberculous regimen of isoniazid, pyrazinamide, cycloserine, moxifloxacin, clofazimine, and linezolid was tailored accordingly. We monitored the drug concentration in his plasma and CSF before (at 0-hour) and after anti-TB drugs administration (at 1-hour, 2-hour, 6-hour, and 12-hour) on 10th day after treatment initiation. We hope to provide reference values of drug exposures in plasma and CSF for patients with pre-XDR-TBM.
Keywords: pre-extensive drug resistant TB, tuberculous meningitis, pharmacokinetics, long-tunneled external ventricular drain, drug concentration